Literature DB >> 1420685

Biliary concentrations of fluconazole in a patient with candidal cholecystitis: case report.

S A Bozzette1, R L Gordon, A Yen, M Rinaldi, M K Ito, J Fierer.   

Abstract

A patient with acute cholecystitis due to Candida albicans and Candida parapsilosis was treated with a percutaneous cholecystostomy and daily intravenous fluconazole. Fluconazole levels in serum and bile were measured by gas chromatography. Fluconazole levels in the bile were equal to those in the blood for the first 8 hours after a dose and were slightly higher than serum levels after that. Bile levels after an oral dose of fluconazole were 15% higher than levels achieved after intravenous administration of the drug. The infection was cured after 2 weeks of treatment. This experience suggests that sufficient fluconazole is excreted in the bile to be effective for treatment of biliary infections due to susceptible yeasts.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1420685     DOI: 10.1093/clind/15.4.701

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  8 in total

1.  Clinical pharmacokinetics of fluconazole in superficial and systemic mycoses.

Authors:  D Debruyne
Journal:  Clin Pharmacokinet       Date:  1997-07       Impact factor: 6.447

Review 2.  Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients.

Authors:  Romuald Bellmann; Piotr Smuszkiewicz
Journal:  Infection       Date:  2017-07-12       Impact factor: 3.553

Review 3.  Recurrent pregnancy loss.

Authors:  Evdokia Dimitriadis; Ellen Menkhorst; Shigeru Saito; William H Kutteh; Jan J Brosens
Journal:  Nat Rev Dis Primers       Date:  2020-12-10       Impact factor: 52.329

Review 4.  Human pharmacogenomic variations and their implications for antifungal efficacy.

Authors:  Joseph Meletiadis; Stephen Chanock; Thomas J Walsh
Journal:  Clin Microbiol Rev       Date:  2006-10       Impact factor: 26.132

5.  Acute cholecystitis and wound infection due to Candida albicans.

Authors:  P López Onrubia; M T Bastida Vilá; J A Martínez Martínez; J Ribas Montfort; N Jové Vidal
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-03       Impact factor: 3.267

6.  Candidal liver abscesses and cholecystitis in a 37-year-old patient without underlying malignancy.

Authors:  Chung-Hsu Lai; Hsin-Pai Chen; Te-Li Chen; Chang-Phone Fung; Cheng-Yi Liu; Shou-Dong Lee
Journal:  World J Gastroenterol       Date:  2005-03-21       Impact factor: 5.742

Review 7.  Commonly used antibacterial and antifungal agents for hospitalised paediatric patients: implications for therapy with an emphasis on clinical pharmacokinetics.

Authors:  J Singh; B Burr; D Stringham; A Arrieta
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

Review 8.  Selective decontamination of the digestive tract: the mechanism of action is control of gut overgrowth.

Authors:  Luciano Silvestri; Miguel A de la Cal; Hendrick K F van Saene
Journal:  Intensive Care Med       Date:  2012-09-22       Impact factor: 17.440

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.